Bone marrow cells plus Bio-Oss graft for repairing severe jawbone defects
Official title: A Clinical Study of Autologous Bone Marrow Mononuclear Cells Combined With Bio-oss® for the Repair of Severe Maxillofacial Bone Defects
Run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · NCT07852806 · Data updated 2026-11-12
This study tests whether using a patient’s own bone marrow–derived mononuclear cells mixed with Bio-Oss graft can repair severe maxillofacial bone defects in adults aged 18-60.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years to 60 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | November 1, 2022 |
| Main results expected | January 1, 2027 |
| Study ends | September 1, 2027 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT07852806 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-60 with severe alveolar bone resorption requiring bone grafting and no major systemic diseases or contraindications to the procedure.
✕Probably not a fit
Patients with poor oral hygiene, concurrent systemic illness, or conditions that affect bone healing may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, single-arm, open-label study conducted at Nanjing Drum Tower Hospital to assess the safety and potential benefit of autologous bone marrow–derived mononuclear cells combined with Bio-Oss bone graft for repairing severe alveolar/jaw bone loss. About 20 eligible adults will undergo 60 mL of autologous bone marrow aspiration, isolation of BMMNCs without expansion, and implantation with Bio-Oss covered by a collagen membrane, followed by postoperative imaging and scheduled follow-ups. Outcomes will include imaging-based assessment of new bone formation and monitoring for adverse events over the follow-up period. The approach aims to shorten treatment timelines and reduce biosafety risks by avoiding in vitro cell expansion.
Why it matters
Potential benefit: If successful, patients may experience improved bone regeneration and better restoration of jaw function with a potentially shorter treatment process.
How similar studies have gone: Similar cell-based grafting approaches have shown promise in bone regeneration, though this exact BMMNC plus Bio-Oss strategy is relatively novel for maxillofacial defects.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with severe alveolar bone resorption caused by inflammation, trauma, or other reasons, requiring bone grafting; * Aged 18 to 60 years; * No systemic diseases such as hypertension, diabetes, heart disease, or immunodeficiency; * Fully informed of the entire study process, willing to participate, and able to sign the informed consent form. Exclusion Criteria: * Patients without maxillofacial bone defects; * Patients with systemic diseases such as hypertension, heart disease, or diabetes; * Patients who have recently received immunosuppressive therapy; * Women who are planning pregnancy, pregnant, or breastfeeding; * Patients with allergic constitution or a history of allergy to drugs or food; * Patients with poor oral hygiene habits who cannot comply with medical advice, which may affect efficacy assessment; * Patients who have participated in other clinical trials within the past 4 weeks.
Where it's running
-
Nanjing Drum Tower Hospital, Nanjing University Medical School
Nanjing, Jiangsu, China Recruiting
Study contacts
- Principal investigator: Haiyan Qin, MD — Nanjing Drum Tower Hospital, Nanjing University Medical School
- Study coordinator: Dongyu Bao
- Email: baodongyu_anson@163.com
- Phone: 15651989007
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two bovine bone grafts in sinus lift with or without jaw marrow blood
This study tests whether adding a small amount of jawbone marrow blood to two bovine bone grafts helps create more new bone and height in sinus lift surgery for adults needing implants.
-
Melatonin Gel in Immediate Molar Implants in the Back of the jaw
In this small study, researchers test whether applying a 1% melatonin gel during immediate molar implant placement in the back of the lower jaw helps with healing and bone formation.
-
Porous zirconia shell to widen the jawbone before implants
A small group of adults with a narrow lower back jaw will try a custom porous zirconia shell placed over bone grafts to see if it helps form good-quality new bone before placing dental implants.
-
Immediate molar implants with customized healing abutments in different socket classes
This study tests placing an implant right after extracting a back tooth and using a custom healing cap to shape the gum from day one, in people needing posterior implants.
-
Thermosensitive THBC + CGF for Bone Building After Wisdom Tooth Removal
This real-world study tests whether a thermosensitive hydroxyethylchitosan with concentrated growth factor can help rebuild bone in the socket after removing a lower wisdom tooth.
-
Regenerative Gel to Support Second Molar Health After Wisdom Tooth Extraction
A 70-patient study is testing whether applying Enamel Matrix Derivative (Emdogain) during the removal of an impacted lower wisdom tooth helps protect the neighboring second molar from tissue defects.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.